Ashley Cordova, Chief Financial Officer at NovoCure Ltd (NVCR), sold 10,235 shares at $76.16 ($779K) on 2023-03-03, disclosed to the SEC on 2023-03-07.
Open-market sale of $779k NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.16 | 775 | $59K | 7.6% |
| 2 | $76.16 | 4,730 | $360K | 46.2% |
| 3 | $76.16 | 4,730 | $360K | 46.2% |
| Total | $76.16 avg | 10,235 | $779K | 100% |
| Filing → |
| NVCR | SELL | 2025-03-03 | $452K | — | Filing → |
| NVCR | SELL | 2024-08-05 | $14K | — | Filing → |
| NVCR | SELL | 2023-09-05 | $19K | — | Filing → |